Concepedia

Jan Dahmén

JD

Statistics

Publications

35

Citations

1.7K

H-Index

22

Active since

1974

Affiliations

Karolinska Institutet(Current)

AstraZeneca (Sweden)

Stockholm University

Lund University

AstraZeneca (United States)

Jan Dahmén is an author at Karolinska Institutet specializing in life sciences, biochemistry, and carbohydrate chemistry.

Publications per year

1974–2017

35

Publications

35

2-(Trimethylsilyl)ethyl glycosides. 3. Synthesis, anomeric deblocking, and transformation into 1,2-trans 1-O-acyl sugars

Karl Jansson, Stefan Ahlfors, Torbjoern Frejd et al. · The Journal of Organic Chemistry · 1988 · 321 citations

, , +15

Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells.

Bengt Åndersson, Jan Dahmén, T. FREJD et al. · The Journal of Experimental Medicine · 1983 · 244 citations · Full text

, , +17

2-Bromoethyl glycosides: synthesis and characterisation

Jan Dahmén, Torbjörn Frejd, Gunnar Grönberg et al. · Carbohydrate Research · 1983 · 111 citations

, , +4

Immunization with glycosylated K<sup>b</sup>‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells

Ussama M. Abdel‐Motal, Louise Berg, Anders Rosén et al. · European Journal of Immunology · 1996 · 85 citations

, , +17

Novel Prostaglandin D Synthase Inhibitors Generated by Fragment-Based Drug Design

M. Hohwy, Loredana Spadola, Britta Lundquist et al. · Journal of Medicinal Chemistry · 2008 · 63 citations · Full text

, , +17

1–5 of 35